Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (241-250 of 340) with videos related to

Pageof 34
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2013
Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trialAlda L Tam, Edward S Kim, J Jack Lee, et al.
Scientific Reports|April 11, 2018
Positive Surgical Margins in the 10 Most Common Solid CancersRyan K Orosco, Viridiana J Tapia, Joseph A Califano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Cyclin D1 and cancer development in laryngeal premalignancy patientsVassiliki Papadimitrakopoulou, Julie G Izzo, Diane D Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancerDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Clinical Pharmacology and Therapeutics|April 24, 2014
Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyXia Pu, Michelle A Hildebrandt, Charles Lu, et al.
Cancer Discovery|February 12, 2017
Interaction Landscape of Inherited Polymorphisms with Somatic Events in CancerHannah Carter, Rachel Marty, Matan Hofree, et al.
Cancer|November 6, 2003
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaVassiliki A Papadimitrakopoulou, Lawrence E Ginsberg, Adam S Garden, et al.
Journal of the National Cancer Institute|April 5, 2018
Met Receptor Tyrosine Kinase and Chemoprevention of Oral CancerPierre Saintigny, William N William, Jean-Philippe Foy, et al.
Oral Oncology|March 5, 2015
Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinomaSharat C Raju, Samantha J Hauff, Aaron J Lemieux, et al.
Pageof 34

Showing results (241-250 of 340) with videos related to

Sort By:
Pageof 34
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2013
Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trialAlda L Tam, Edward S Kim, J Jack Lee, et al.
Scientific Reports|April 11, 2018
Positive Surgical Margins in the 10 Most Common Solid CancersRyan K Orosco, Viridiana J Tapia, Joseph A Califano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancerCarol M Moinpour, Nancy L Vaught, Bryan Goldman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Cyclin D1 and cancer development in laryngeal premalignancy patientsVassiliki Papadimitrakopoulou, Julie G Izzo, Diane D Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancerDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Clinical Pharmacology and Therapeutics|April 24, 2014
Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyXia Pu, Michelle A Hildebrandt, Charles Lu, et al.
Cancer Discovery|February 12, 2017
Interaction Landscape of Inherited Polymorphisms with Somatic Events in CancerHannah Carter, Rachel Marty, Matan Hofree, et al.
Cancer|November 6, 2003
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaVassiliki A Papadimitrakopoulou, Lawrence E Ginsberg, Adam S Garden, et al.
Journal of the National Cancer Institute|April 5, 2018
Met Receptor Tyrosine Kinase and Chemoprevention of Oral CancerPierre Saintigny, William N William, Jean-Philippe Foy, et al.
Oral Oncology|March 5, 2015
Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinomaSharat C Raju, Samantha J Hauff, Aaron J Lemieux, et al.
Pageof 34